Insulin glargine 300 U/<scp>ml</scp> versus insulin degludec 100 U/<scp>ml</scp> improves nocturnal glycaemic control and variability in type 1 diabetes under routine clinical practice: A glucodensities‐based post hoc analysis of the <i>OneCare</i> study-Reference-Cited by-同舟云学术

Insulin glargine 300 U/ml versus insulin degludec 100 U/ml improves nocturnal glycaemic control and variability in type 1 diabetes under routine clinical practice: A glucodensities‐based post hoc analysis of the OneCare study

Published:2024-02-20 Issue:5 Volume:26 Page:1993-1997
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Gomez‐Peralta Fernando¹^ORCID,Chico Ballesteros Ana²,Marco Martínez Amparo³,Pérez Corral Begoña⁴,Conget Donlo Ignacio⁵,Fuentealba Melo Paulina⁶,Zaragozá Arnáez Fernando⁷^ORCID,Matabuena Rodríguez Marcos⁸

Affiliation:

1. Endocrinology and Nutrition Unit Hospital General de Segovia Segovia Spain

2. Department of Endocrinology and Nutrition Hospital Santa Creu i Sant Pau, Barcelona, Spain. CIBER‐BBN, Instituto de Salud Carlos III, Madrid, Spain. Universitat Autònoma de Barcelona Barcelona Spain

3. Endocrinology and Nutrition Unit Hospital Universitario de Toledo Toledo Spain

4. Endocrinology and Nutrition Unit Hospital de Leon Leon Spain

5. Diabetes Unit, Department of Endocrinology and Nutrition IDF Centre of Education and Excellence in Diabetes Care, ICMDM, IDIBAPS, Hospital Clínic Barcelona Spain

6. Sanofi Barcelona Spain

7. Sanofi Madrid Spain

8. CiTIUS (Centro Singular de Investigación en Tecnoloxías Intelixentes) Universidade de Santiago de Compostela Santiago de Compostela Spain

Funder

Sanofi España

Publisher

Wiley

Reference19 articles.

1. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

2. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

3. International Consensus on Use of Continuous Glucose Monitoring

4. Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study;Gómez‐Peralta F;Endocrinol Diabetes Nutr (Engl Ed),2021

5. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review;Advances in Therapy;2024-08-02

2. Nocturnal Glucose Profile According to Timing of Dinner Rapid Insulin and Basal and Rapid Insulin Type: An Insulclock® Connected Insulin Cap-Based Real-World Study;Biomedicines;2024-07-18